Skip to main content

Gentherm Medical Launches ASTOPAD™ Patient Warming System

Written by Customer Service on . Posted in Public Companies.

NORTHVILLE, Mich., Oct. 15, 2020 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), a global market leader and developer of innovative thermal management technologies today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has launched the ASTOPADTM Patient Warming System in the United States. The ASTOPAD system can be utilized in all surgical procedures and helps prevent and treat hypothermia in patients throughout the perioperative journey.
The ASTOPAD Patient Warming System is a proven device that has been utilized by hospitals outside the United States since 1989. The system consists of a silent electronic controller and a selection of proprietary warming blankets. The controller has two cable connections that can control two blankets simultaneously. A warming blanket can be placed over and/or under the patient, where the temperature settings of the controller range from 32°C – 39°C, and can be set individually in precise 0.5°C increments.All ASTOPAD blankets are made of Gentherm’s proprietary carbon fiber heating technology, where each blanket is designed with eight integrated sensors enabling enhanced patient safety and precise temperature control. The heating technology has been installed in over 80 million vehicles. Its unique, grid-like design enables safety, durability and reliability.“The launch of the ASTOPAD Patient Warming System demonstrates our deep understanding of human thermophysiology and how we are able to leverage technology from our automotive business to provide advancements in patient temperature management in our medical business,” said Phil Eyler, President and CEO of Gentherm. “Our carbon fiber heating technology was originally designed for comfort, warmth, reliability and safety in automotive passenger thermal management. This technology is ideal for the Operating Room and anywhere in a hospital when medical professionals need quiet, comfortable and reliable warming to help prevent and treat hypothermia in a surgical patient.”The ASTOPAD system is compliant with all the latest electrical, ISO and safety standards for a medical patient warming device.Investor Contact
Yijing Brentano, Gentherm
investors@gentherm.com 
248.308.1702Media Contacts
Melissa Fischer, Gentherm
media@gentherm.com 
248.289.9702About Gentherm
Gentherm (NASDAQ:THRM) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery thermal management systems, cable systems and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has over 11,000 employees in facilities in the United States, Germany, Canada, China, Hungary, Japan, South Korea, North Macedonia, Malta, Mexico, United Kingdom, Ukraine, and Vietnam.  For more information, go to www.gentherm.com.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.